{"prompt": "['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix S:', 'Sample Serious Adverse Event Form (Continued)', 'AMGEN', 'Clinical Trial Serious Adverse Event Report - Phase 1-4', 'New', 'CC-10004-PSOR-020', 'Notify Amgen Within 24 Hours of knowledge of the event', 'Apremilast (Otezia)', 'Follow-up', 'Reminder: Enter the SAE information into RAVE and then send the paper Serious', 'Adverse Event Report', 'Site Number', 'Subject ID Number', '6. CONCOMITANT MEDICATIONS (eg. chemotherapy', 'Any Concomitant Medications?', 'No Yes, If yes please complete:', 'Start Date', 'Medication Name(e)', 'Stop Date', 'Co-suspect', 'Continuing', 'Treatment Med', 'Dose', 'Route', 'Freq.', 'Dey', 'Venth', 'Year', 'Day', 'Month', 'Year', 'Nor', 'Yen', 'No/', 'Yesr', 'No-', '7. RELEVANT MEDICAL HISTORY (include dates, allergies and any relevant prior therapy)', '8. RELEVANT LABORATORY VALUES (include baseline values) Any Relevant Laboratory values?', 'No', 'Yes, If yes, please complete:', 'Test', 'Unit', 'Date', 'Dap', 'Verth', 'Year', '9. OTHER RELEVANT TESTS (diagnostics and procedures)', 'Any Other Relevant tests?', 'No', 'Yes, If yes, please complete:', 'Date', 'Additional Tests', 'Results', 'Units', 'De Verth', 'FORM-015482 Clinical Trial SAE Report - Phase 1-4 V 10.0 Effective date: 23-April-2018', 'SAER Created 02-April-2020', 'Page 2 of 3', 'Confidential and Proprietary', '96', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix S:', 'Sample Serious Adverse Event Form (Continued)', 'AMGEN', 'Clinical Trial Serious Adverse Event Report - Phase 1-4', 'New', 'CC-10004-PSOR-020', 'Notify Amgen Within 24 Hours of knowledge of the event', 'Apremilast (Otezia)', 'Follow-up', 'Reminder: Enter the SAE information into RAVE and then send the paper Serious', 'Adverse Event Report', 'Site Number', 'Subject ID Number', '10. CASE DESCRIPTION (Provide narrative details of events listed in section 3) For each event in section 3, where relationship=Yes', 'please provide rationale.', 'Signature of Investigator or Designee', 'Title', 'Date', '/ confirm by signing this report that the information an this form, including', 'seriousness and cousality assessments, is being provided to Amgen by the', 'Investigator for this study, or by a Qualified Medical Peyson authorized by the', 'Investigator for this study.', 'FORM-015482 Clinical Trial SAE Report- - Phase 1-4 V 10.0 Effective date: 23-April-2018', 'SAER Created 02-April-2020', 'Page 3 of 3', 'Confidential and Proprietary', '97', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix T: Pregnancy Notification Form', 'Amgen Proprietary Confidential', 'AMGEN', 'Pregnancy Notification Form', \"Please refer to your site's Pregnancy Notification Form for Amgen Safety's Country Fax Number\", \"and if Fax is unavailable, Amgen Safety's Country email address.\", '1. Case Administrative Information', 'Protocol/Study Number: CC-10004-PSOR-020', 'Study Design:', 'Interventional', 'Observational (If Observational:', 'Prospective', 'Retrospective)', '2. Contact Information', 'Investigator Name', 'Site #', 'Phone (', ')', 'Fax (', ')', 'Email', 'Institution', 'Address', '3. Subject Information', 'Subject ID #', 'Subject Gender:', 'Female', 'Male', 'Subject age (at onset):', '(in years)', '4. Amgen Product Exposure', 'Dose at time of', 'Amgen Product', 'Frequency', 'Route', 'Start Date', 'conception', 'mm', 'Add', 'Was the Amgen product (or study drug) discontinued?', 'Yes', 'No', 'If yes, provide product (or study drug) stop date: mm', '/dd', 'Did the subject withdraw from the study?', 'Yes', 'No', '5. Pregnancy Information', \"Pregnant female's last menstrual period (LMP)\", 'mm', '/ dd', 'Unknown', 'N/A', 'Estimated date of delivery mm', '/ dd', '/', 'If N/A. date of termination (actual or planned) mm', '/ dd', '/', 'Has the pregnant female already delivered?', 'Yes', 'No', 'Unknown', 'N/A', 'If yes, provide date of delivery. mm', 'dd', '/', 'Was the infant healthy?', 'Yes', 'No', 'Unknown', 'N/A', 'If any Adverse Event was experienced by the infant, provide brief details:', 'Form Completed by:', 'Print Name:', 'Title:', 'Signature:', 'Date:', 'FORM-115199', 'Version 1.0', 'Effective Date: 24-Sept-2018', 'Confidential and Proprietary', '98', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']\n\n###\n\n", "completion": "END"}